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Summary
Rationale: Infradiagnosis of chronic obstructive pulmonary disease (COPD) may be
related to the lack of knowledge about the disease and/or the scarce use of
diagnostic procedures. This study analyses the frequency of respiratory symptoms
and the knowledge about COPD in the general population, together with the use of
spirometry in individuals at risk of COPD.
Population and method: A telephone survey was carried out in 6758 subjects older
than 40 years, stratified by age, habitat (urban or rural) and region, screened by
random-digit dialling.
Results: Up to 24% reported having at least one chronic respiratory symptom and 20.9%
had a self-reported respiratory diagnosis. A total of 19.2% were active smokers and 40%
had never tried to quit. Only 60% of the individuals with chronic symptoms had
consulted a physician and, of them, only 45% had undergone spirometry. Spirometry was
mentioned more frequently by subjects attended by pulmonologists than by GPs (67.6
vs. 28.6%; Po0.001). The term COPD was identified only by 8.6% of the participants.
Conclusions: Many individuals with respiratory symptoms do not request medical
attention and do not attempt to quit smoking. There is a lack of knowledge about
COPD. Physicians should more actively inform about the disease and increase the use
of spirometry for early detection.
& 2006 Elsevier Ltd. All rights reserved.
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Introduction
Chronic obstructive pulmonary disease (COPD) is a
frequent cause of morbidity and mortality in devel-
oped countries. Despite campaigns against tobacco
smoking, the prevalence of this disease and mortality
rates due to COPD continue to increase. From 1979 to
1993, the age-adjusted mortality rate in the United
States increased 47.3%1 and it is still on the rise.
COPD represents a large economic burden to
society. The mean annual direct medical cost of a
patient with COPD in Spain has been quantified as
$18762 and up to $10,812 for severe patients in the
US.3 One economic study has demonstrated that
the best strategy to reduce costs in COPD is early
diagnosis of the disease, with adequate manage-
ment in early stages.4 This is explained by the fact
that the costs of a severe case are as much as seven
times higher than those of a mild case.3,5 However,
several studies have demonstrated that a large
proportion of patients with COPD in the community
remains undiagnosed6–8 and this lack of diagnosis
prevents patients from receiving smoking cessation
counselling with adequate treatment and follow-
up. The reason for the underdiagnosis and the delay
in diagnosis may stem, at least in part, from a lack
of knowledge of the importance of respiratory
symptoms by the individual at risk and also by some
physicians. In addition, despite the high prevalence
and economic and societal burden, the term COPD
does not seem to be well recognised and under-
stood by the general population. Therefore, in-
dividuals at risk may not seek attention to diagnose
and treat a condition of which they are not aware.
The aim of this survey was to obtain information on
the frequency of respiratory symptoms and self-
reported diagnosis of respiratory conditions in a
representative sample of the general adult population.
In addition, we investigated the knowledge about
COPD and some aspects of respiratory care, such as
the use of spirometry in individuals with chronic res-
piratory symptoms. As a mean of collecting informa-
tion from a large sample of individuals in a reasonable
time frame, a telephone interview was designed for
the study. The methodology developed was similar to
that used in a recent telephone survey successfully
conducted in patients with chronic lung disease.9
Method
Subject selection
The survey was performed by telephone contact in
all regions of Spain, including the Balearic and
Canary islands. Participation in the survey was
voluntary, confidential and anonymous. In Spain,
90% of the households have a telephone.
Sampling was performed according to the follow-
ing criteria: (a) stratification of the population
older than 40 years in decades (40–50, 51–60,
61–70, 470 years); (b) number of telephone
interviews per site of habitat (ruralo10,000 and
urban 410,000 inhabitants) in accordance with
their distribution among the Spanish population; (c)
distribution by age and site of habitat within each
of the 17 autonomous communities of Spain. The
sampling method used telephone numbers ran-
domly generated by a truncated list-assisted ran-
dom-digit random procedure.10
This design required 384 interviews in each of the
17 autonomous communities of Spain; with makes
an expected total of 6528 interviews. This allows
equal sample precision in the population estimates
with an error of 5% and a power of 80% for a
population prevalence of the different respiratory
symptoms of at least 5%, thereby making the global
sample representative of each of the autonomous
communities for each site of habitat (rural/urban)
as well as for each age group.
Collection of data
The telephone interview was carried out by multi-
ple previously trained interviewers. The timetable
covered was from 14:00 to 21:30 on workdays with
the interview lasting a mean of 15min. Prior to
initiation, a pilot study was performed in 50
individuals on questionnaire feasibility and com-
prehension with grammatical modifications being
made as required.
On dialling a telephone number, several things
could be expected: the number may not correspond
to a residence or home, and was then randomly
substituted; nobody answered the phone, and if
after a maximum of four times there continued to
be no answer, it was considered as not contacted.
Another option was refusal to be interviewed.
Lastly, an eligible individual may have been absent.
This number was then placed in the ‘‘postponed’’
box with the day/time, which the subject was
expected to be at home.
The survey questionnaire was based on the
European Commission for Steel and Coal (ECSC)
questionnaire translated and validated in Span-
ish.11 This questionnaire has been previously used
in a large epidemiological survey in Spain,6,12 with
additional questions on knowledge of COPD, use of
spirometry and perception of severity of other
chronic diseases. The Medical Research Council
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(MRC) dyspnoea scale, modified according to
Bestall et al.13 was incorporated into the ques-
tionnaire, as a measure of dyspnoea severity, and
ranged from 0 to 5, being 0 not dyspnoea at all and
5 too breathless to leave the house. An individual
was considered to have significant dyspnoea with a
score of at least 3 (‘‘Have to stop even when
walking at my own pace of walk slower than most
people my age’’), which is the minimum level
considered to be representative of some limitation
of activity due to breathlessness during daily life.13
Regarding knowledge of COPD, the participating
individuals were asked about their spontaneous
knowledge of respiratory diseases considered se-
vere or frequent with no orientation from the
interviewer. At the same time, their knowledge of
COPD was determined with a question using the
term COPD (EPOC in Spanish). This was termed
spontaneous knowledge. Those who spontaneously
knew about COPD were requested to enumerate
the symptoms they relate directly with the disease.
The ‘‘suggested knowledge’’ of COPD was investi-
gated in respondents who had no spontaneous
knowledge of COPD. They where asked again after
being given a definition of the disease including the
kind of disease, the processes included in the
definition, the main aetiology and symptoms.
Statistical analysis
For the purpose of analysis, patients were divided
into non-smokers or smokers and ex-smokers. A
subgroup of individuals, smokers or ex-smokers, were
defined as having high risk of COPD by being 55 years
of age or older and having a cumulative tobacco
consumption of at least 20 pack-years. A descriptive
analysis was made with the elaboration of frequency
tables for the nominal variables and measures of
central trends and dispersion for the continuous
variables. The Chi-square test was used to analyse
the relationship between categorical variables. The
Student’s t test was used for continuous variables in
cases of variables normality and in cases to the
contrary non-parametric tests were used. All statis-
tical tests were two-sided and comparisons with a
probability of erroro5% were considered significant.
Results
Characteristics of the population
To reach the required number of interviews, a total
of 20,173 telephone contacts were necessary. One
or more persons 40 years in age were identified and
contacted in these homes surveyed on 15,812
occasions (78.4%) with 6758 (42.7%) questionnaires
being completed, giving an overall response rate of
38%. This response rate was similar to the response
observed in other studies using telephone survey.9 A
flow chart of the study is depicted in Fig. 1.
The clinical and demographical characteristics of
the individuals surveyed, according to the smoking
habits and the risk of COPD are presented in Table 1.
The mean age of the subjects was 58 years (SD: 12.3
years) with 70.2% being women. In regard to
smoking, 62.8% of the people surveyed had never
smoked, 19.2% smoked and 18% were ex-smokers. At
some time 58.8% of the current smokers had
attempted to quit, with a mean of 3.9 attempts, a
number which increased to 4.5 (Po0.05) in the high
risk of COPD group. In respondents who had tried to
quit smoking at least once, respiratory symptoms
were more frequent (66.7 vs. 54.6%, Po0.0001)
with a higher percentage of self-reported respira-
tory diseases (67.2 vs. 56.4%, Po0.0001).
Prevalence of respiratory symptoms and self-
reported diagnosis of respiratory diseases
A total of 1622 (24%) individuals reported at least
one chronic respiratory symptom, of which 585
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20,173 telephone contacts 
17,688 homes with adults over 40 years 
2,485 contacts without individuals over 40 years 
1,876 impossible to establish contact 
351 deemed too ill to conduct the survey 
7,340 refused to conduct the survey 
8,121 accepted doing the questionnaire 
1,354 partial/incomplete interview 
6,767 completed questionnaires 
6,758 final analysis 
9 not included in stratification groups  
Figure 1 Selection of the population surveyed.
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(8.7%) referred two or more symptoms. The
percentage of individuals with respiratory symp-
toms increased in the group of smokers and
exsmokers and further increased in the group of
high risk of COPD (Fig. 2).
A total of 1412 subjects (20.9%) reported being
diagnosed with a respiratory disease, the most
frequent being acute bronchitis (14%). Only 29
respondents (0.43%) indicated having been diag-
nosed with COPD, of whom 22 (76.6%) had under-
gone spirometry, and only 12 (41.4%) were
receiving treatment. In the group of high risk of
COPD 9 individuals had a self-reported diagnosis of
COPD (1.6%), but 8.8% diagnosed chronic bronchitis
and 3.4% emphysema. The frequency of the
diagnosis of asthma was very similar in all the
groups analysed (Fig. 3).
Use of spirometry
Only 60.8% of the subjects questioned who had
some symptom had consulted their physician (56.4%
to the general practitioner, 43.6% to the pneumol-
ogist). Even among patients with high risk of COPD,
only 66.8% of individuals with symptoms had
consulted to a physician, but the number of those
who attended a pulmonologist increased up to
60.2%. Among those who had consulted their
physician 45.6% underwent spirometry (Fig. 4).
The percentage of persons in whom spirometry was
performed was greater in males versus females
(58.1 vs 36.3%; Po0.0001), Likewise, smokers and
ex-smokers were more likely to have undergone
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Table 1 Demographic and clinical characteristics of the individuals surveyed.
Total
(n ¼ 6758)
Non-smokers
(n ¼ 4246)
Smokers and ex-
smokers
(n ¼ 2512)
High risk of
COPD
(n ¼ 534)
Sex, men (%) 29.8 17.6 50.5z 77.9z
Age, years (SD) 58 (12.3) 60.4 (11.8) 54 (12)z 67.2 (8.1)z
Pack-years (SD) 23.3 (25.1) 0 23.3 (25.1)y 43.5 (32.2)
Have tried to quit smoking
(active smokers only) (%)
58.8 0 58.8y 63.3
Attempts (SD) (active smokers
only)
3.9 (7.1) 0 3.9 (7.1)y 4.5 (8.8)
Any respiratory symptom (%) 1622 (24) 913 (21.5) 709 (28.2)y 216 (40.4)y
Number of symptoms
0 5136 (76) 3333 (78.5) 1803 (71.8)y 318 (59.5)z
1 1037 (15.3) 627 (14.7) 410 (16.3) 113 (21.1)
2 358 (5.3) 190 (4.5) 168 (6.7) 57 (10.7)
3 158 (2.3) 62 (1.4) 96 (3.8) 33 (6.2)
4 69 (1.1) 34 (0.8) 35 (1.4) 13 (2.4)
Consulted a physician (%) 978 (60.8) 592 (65.2) 386 (55.1)y 143 (66.8)
General practitioner (%) 56.4 59.6 51.5 39.8y
Specialist (%) 43.6 40.4 48.5 60.2
Spirometry performed (%) 446 (45.6) 228 (38.5) 218 (56.4)z 86 (60.1)z
Any respiratory diagnosis (%) 20.9 19.6 23.1 29.4y
Po0.05 compared with non-smokers.
yPo0.01 compared with non-smokers.
zPo0.001 compared with non-smokers.
yPo0.05 compared with individuals at high risk of COPD.
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Figure 2 Frequency of respiratory symptoms in the
respondents according to smoking habits and risk of
COPD. *Po0.05 compared with non-smokers; &Po0.01
compared with non-smokers; CMH ¼ chronic mucus
hypersecretion.
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spirometry (56.4%) compared to non-smokers
(38.5%) (Po0.0001). Among those with respiratory
symptoms seen by a general physician, 28.6% had
spirometry compared with 67.6% of those visited by
a chest physician (Po0.0001). To rule out a bias for
severity; i.e. those more severe were attended by a
chest physician and had more chances to have a
spirometry; the differences persisted in the group
with high risk of COPD (38.6 vs 74.4%; Po0.001).
Knowledge of COPD and other respiratory
diseases
Only 8.6% of the population surveyed had any
spontaneous knowledge about COPD. This percen-
tage decreased with an increase in age (11, 8.8, 6.9
and 5.9% for each decade from 40 to 80 years of
age; Po0.0001). Knowledge was greater in smokers
and ex-smokers than in non-smokers (11.8 versus
6.7%; Po0.05) (Table 2). Among those with
spontaneous knowledge of COPD, up to 44.4% were
not able to mention any symptom characteristic of
the disease. dyspnoea was the symptom most
frequently related to COPD (46%) (Table 2). The
most frequent source of information was the mass
media, followed by the family environment. Inter-
estingly, only 27.6% of smokers or ex-smokers who
knew about COPD obtained this information from a
physician. In contrast, when the participants were
asked to mention chronic respiratory diseases,
32.3% spontaneously mentioned bronchitis, 30.9%
asthma, and 29.5% chronic bronchitis. The percen-
tage of individuals with ‘‘suggested’’ knowledge of
COPD increased considerably; but even under these
circumstances, 21.7% of the total and 18.8% of
smokers or ex-smokers did not know about COPD.
No significant differences were found in the
suggested knowledge of COPD between men and
women (9.1% and 8.4%, respectively).
When questioned about their perception of
severity of COPD with a scale of 1–10, the mean
score was 8.3. This perception of severity was
lower with the increase in age (8.5, 8.4, 8.3 and
8.1, respectively, per age group; Po0.0001).
Women perceived COPD with greater severity than
men (8.5 vs. 8.1; Po0.0001). In comparison with
other chronic diseases, only ischaemic heart dis-
ease scored higher than COPD (Table 2).
Discussion
The main findings of the study were that only 8.6%
of participants knew about COPD, and even when
suggested by the interviewer, 21.7% did not identify
the disease. However, among those who identified
the disease, COPD was perceived as a serious
disease. Up to 24% of the general population over
40 years in age reported having at least one chronic
respiratory symptom, and 20.9% had a self-reported
respiratory diagnosis. However, only 60% of indivi-
duals with chronic symptoms had consulted a
physician and, only 45% of them underwent
spirometry. Spirometry was requested more fre-
quently by pulmonary specialists than by general
practitioners.
The methods used in the current study are similar
to those used in a recent international survey.9 The
strengths and limitations have been discussed
extensively elsewhere.9,10 In fact, this study can
not be considered a prevalence study, but provides
true estimates of the frequency of symptoms and
self-reported diagnosis in a large population, not
submitted to interviewer control over sample selec-
tion and provides anonymity for the respondent. The
prevalence of chronic respiratory symptoms in our
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Respondents 
6,758 
No respiratory symptoms                Respiratory symptoms 
4,314 (64%)                                      2,444 (36%)
Did not consult physician               Consult physician
1,073 (44%) 1,371 (56%) 
 No spirometry                             Spirometry
786 (57.4%)                                585 (42.6%)
Figure 4 Flow-chart of diagnosis of individuals with
respiratory symptoms.
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%
Figure 3 Frequency of self-reported respiratory diagno-
sis in the respondents according to smoking habits and
risk of COPD. AB ¼ acute bronchitis; Ast ¼ asthma;
CB ¼ chronic bronchitis; COPD ¼ chronic obstructive
pulmonary disease; Emp ¼ emphysema.
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population was somewhat lower than that found in a
previous study in Spain, in which 48% of paticipants
reported at least one symptom.12 This prevalence is
similar to the 40.4% found in our population of
individuals defined as at risk of COPD by being older
than 55 years and with a tobacco consumption of at
least 20 pack-years. Differences may be due to the
different characteristics of the populations studied,
And the design of the study. Those without a
telephone may represent a lower socio-economic
status group with a higher smoking prevalence and
presumably a higher prevalence of respiratory
symptoms and disease and even lesser knowledge
of COPD. Our results, however, were more similar to
those reported in other countries; as an example,
among subjects older than 30 years in Finland, 23.8%
of men and 13.8% of women reported having chronic
cough and phlegm.14 Similarly, 12.6% of individuals
between 20 and 59 years in Sweden reported chronic
cough and 15.1% chronic sputum production.15
Among self-reported diagnoses, the prevalence
of chronic bronchitis or emphysema was 5.8%,
which is very similar to the 4.6% in the Swedish
study15 and 4% found in a survey in France in
individuals above 25 years of age.16 However, since
only 60.8% of those with respiratory symptoms in
our study requested medical attention, and spiro-
metry was performed in only 45.6%, this number
probably underestimates the real prevalence of
chronic obstructive lung disease in the general
population. Underdiagnosis of chronic bronchial
diseases is well recognised in epidemiological
studies.6–8,16 Reasons for this underdiagnosis stem,
in part, from the patients; because, even among
individuals at high risk of COPD with chronic
respiratory symptoms, 33.2% had never consulted
a physician. The other reason for the under-
diagnosis stems from the physicians, since among
those who consulted the physician, only 60.1%
underwent spirometry. There is a need to increase
the awareness of COPD, particularly among general
practitioners, because spirometry was only per-
formed in 38.6% of high-risk individuals who
consulted for chronic repiratory symptoms. This
result is almost identical to that observed by
Naberan Ton˜a17 in another survey in Spain about
10 years ago, in which only 36.4% of primary-care
physicians requested spirometry in patients with
suspected COPD, and in large epidemiological
surveys, which show that less than 50% of indivi-
duals diagnosed with COPD in primary care have
undergone spirometry.2,18 Results in other countries
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Table 2 Knowledge about COPD and perception of severity of COPD and other chronic diseases.
Total
(n ¼ 6758)
Non-smokers
(n ¼ 4246)
Smokers and ex-
smokers
(n ¼ 2512)
High risk of
COPD
(n ¼ 534)
Spontaneous knowledge of COPD (%) 574 (8.6) 284 (6.7) 290 (11.8) 53 (10)
Source of information about COPD (%)
Mass media 245 (42.7) 125 (44) 120 (41.3) 24 (45.3)
Physician 139 (24.2) 59 (20.7) 80 (27.6) 12 (22.6)
Pharmacist 22 (3.8) 8 (2.8) 14 (4.8) 1 (1.9)
Relative 191 (33.3) 104 (36.6) 87 (30) 18 (33.9)
Symptoms mentioned (%)
Cough 103 (17.9) 56 (19.7) 47 (16.2) 6 (11.3)
Wheezing 78 (13.6) 33 (11.6) 45 (15.5) 6 (11.3)
CMH 74 (12.9) 39 (13.7) 35 (12) 6 (11.3)
Dyspnoea 264 (45.9) 129 (45.4) 135 (46.5) 21 (39.6)
No answer 255 (44.4) 126 (44.3) 129 (44.4) 28 (52.8)
Suggested knowledge of COPD (%) 5295 (78.3) 3256 (76.7) 2039 (81.2)y 424 (79.4)
Perception of severity of COPD 8.3 (1.6) 8.3 (1.6) 8.3 (1.6) 8.1 (1.7)y
Perception of severity of
Diabetes 7.7 (1.8) 7.7 (1.7) 7.5 (1.8) 7.4 (1.9)
Hypertension 7.6 (1.7) 7.6 (1.7) 7.4 (1.7) 7.3 (1.8)
IHD 8.7 (1.6) 8.7 (1.5) 8.7 (1.5) 8.7 (1.5)
Gastric ulcer 7.0 (1.7) 7.1 (1.7) 6.9 (1.7) 6.8 (1.8)
Arthrosis 7.8 (1.7) 7.9 (1.7) 7.6 (1.7) 7.6 (1.8)
Po0.05 compared with non-smokers.
yPo0.01 compared with non-smokers.
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suggest that this is a widespread problem. In
France, pulmonary function was evaluated by
spirometry or a peak flow metre in only 45% of
individuals with chronic bronchitis and only 7%
were regularly followed for the disease.16 In an
international survey performed in some European
countries, the US and Canada (Confronting Inter-
national Survey), 62.4% of subjects with COPD were
followed by general practitioners and only 45.5% of
the patients had undergone spirometry during the
year previous to the survey.9 This is of paramount
importance, since general practitioners are the
first contact of the potential COPD patient within
the public health care system, where early detec-
tion should be carried out. Some previous experi-
ences have demonstrated that airway obstruction
can be detected among subjects at risk in primary
care with very simple and relatively cheap inter-
ventions19–21; however, proper diagnosis of COPD in
the community is very often delayed until FEV1
shows a severe impairment.22,23 Guidelines must
stress the importance of performing spirometry in
adults with respiratory symptoms and health
authorities must facilitate the performance of the
test with trained personnel and an adequate time
for the technique to be performed in primary care.
The importance of early intervention is high-
lighted by the finding that 41.2% of active smokers
have never tried to quit. Again, this result is almost
identical to that observed in a previous epidemio-
logical study in Spain performed between 1997 and
1998, in which 38.5% of smokers had never tried to
quit.24 These findings suggest that, unfortunately,
no significant advances in the perception of some
aspects of chronic bronchial diseases among the
population and general practitioners have occurred
in Spain during the last decade.
One important drawback for the understanding
of the population and general practitioners of the
relevance of chronic obstructive lung diseases may
derive from the name. We have observed that COPD
is not recognised by the general population. Only
8.6% knew about COPD. Moreover, 44.4% were not
able to mention any symptom characteristic of the
disease. In contrast, more than 30% recognised
bronchitis or asthma. Physicians, and particularly
general practitioners, must play a key role in
diffusing knowledge of COPD. It is of note that only
24.2% of participants who declared to know the
disease, obtained this information from their
doctors, the main source of information about
COPD being the mass media and familiar relatives.
It is important to use the name of COPD and explain
its meaning and clinical manifestations, specially to
smokers and individuals with respiratory symptoms.
Another result derived from our study indicates
that when COPD is explained to the participants
they perceive it as a serious disease. Among a list of
chronic diseases, only ischaemic heart disease
scored higher in a scale of severity.
In summary, there is a high prevalence of chronic
respiratory symptoms in the general adult popula-
tion. However, there is a lack of information on the
importance of these symptoms and many indivi-
duals do not request medical attention and many
do not attempt to quit smoking. In addition, there
is a lack of knowledge about COPD in the general
population. Physicians, in particular general practi-
tioners, should more actively inform about the
disease, especially in smokers and individuals with
respiratory symptoms, and increase the use of
spirometry to detect the disease at earlier stages.
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